SLNO   $52.66  -1.66% Market Closed After Close 52.73 0.13%

Soleno Therapeutics Inc
Total Cash 266.12M
totalCashPerShare 6.846
EBITDA -66.53M
Total Debt 296.00K
quickRatio 29.084
currentRatio 29.235
Total Revenue
debtToEquity 0.105
Revenue/Share
ROA -0.25552
ROE -0.44619998
grossProfits
freeCashflow -23.13M
operatingCashflow -42.83M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.79B
forwardPE -25.161905
floatShares 18.17M
sharesOutstanding 38.87M
sharesShort 4.49M
sharesShortPriorMonth 3.96M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.07%
Short Ratio help_outline 7.91%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 7.314
Price To Book help_outline 7.22
earningsQuarterlyGrowth
netIncomeToCommon -65.41M
trailingEps -1.83%
forwardEps -2.10%
enterpriseToEbitda -26.88
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.63 3Q 2024
institutionsCount 164
lastUpdated Sept. 16, 2024, 3:14 p.m.